Immunosenescence and late life depression

Central-European Journal of Immunology

Volumn 34, Issue 4, 2009, Pages 271-275

  Rybka, Joanna ^a   Kȩdziora Kornatowska, Kornelia ^b   Kȩdziora, Józef ^a   Kucharski, Robert ^c  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c Center of Psychoneurology in Elderly   (Poland)

Author keywords

Immunosenescence; Late life depression; Low grade inflammation; Metallothioneines; Oxidative stress; Zinc

Indexed keywords

ANTIOXIDANT; METALLOTHIONEIN; ZINC;

ACUTE PHASE RESPONSE; ADAPTIVE IMMUNITY; AGING; DEPRESSION; HUMAN; INFLAMMATION; INNATE IMMUNITY; PREVALENCE; REVIEW; SENESCENCE; ZINC DEFICIENCY;

EID: 75349086654     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Schoevers RA, Beekman AT, van Tilburg W (2000): Association of depression and gender with mortality in old age. Results from the Amsterdam Study of the Elderly (AMSTEL). Br J Psychiatry 177: 336-342.
2. Marcellini F, Giuli C, Papa R et al. (2006): Psychosocial aspects and zinc status: is there a relationship with successful aging? Rejuvenation Res 9: 333-337.
3. Murphy E, Smith R, Lindesay J, Slattery J (1988): Increased mortality rates in late-life depression. Br J Psychiatry 152: 347-353.
4. Schulz R, Beach SR, Ives DG et al. (2000): Association between depression and mortality in older adults: the cardiovascular health study. Arch Intern Med 160: 1761-1768.
5. Rozzini R, Sabatini T, Frisoni GB et al. (2002): Depressive symptoms and negative outcomes in older hospitalized patients. Arch Intern Med 162: 948-949.
6. Ryan J, Carriere I, Ritchie K et al. (2008): Late-life depression and mortality: influence of gender and antidepressant use. Br J Psychiatry 192: 12-18.
7. Wulsin LR, Vaillant GE, Wells VE (1999): A Systematic review of the mortality of depression. Psychosom Med 61: 6-17.
8. Barth J, Schumacher M, Herrmann C (2004): Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 66: 802-813.
9. Carney RM, Freedland KE, Miller GE, Jaffe AS (2002): Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 53: 897-902.
10. Carney RM, Sheps DS (2004): Depression is a risk factor for mortality in coronary heart disease. Psychosom Med 66: 799-801.
11. Abas M, Hotopf M, Prince M (2002): Depression and mortality in a high-risk population. 11-Year follow-up of the medical research council elderly hypertension trial. Br J Psychiatry 181: 123-128.
12. Sable J, Dunn LB, Zisook S (2002): Late-life depression. How to identify its symptoms and provide effective treatment. Geriatrics 57: 18-35.
13. Lett HS, Blumenthal JA, Babyak MA et al. (2004): Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 66: 305-315.
14. Rudisch B, Nemeroff CB (2003): Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54: 227-240.
15. Musselman DL, Evans DL, Nemeroff CB (1998): The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55: 580-592.
16. Joynt KE, Whellan DJ, O'Connor CM (2003): Depresssion and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 54: 248-261.
17. Mykletun A, Bjerkeset O, Dewey M et al. (2007): Anxiety, Depression, and Cause-Specific Mortality: The HUNT Study. Psychosom Med 69: 323-331.
18. Eaton WW (2002): Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res 53: 903-906.
19. Eaton WW, Armenian H, Gallo J et al. (1996): Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 19: 1097-1102.
20. Penninx B, Guralnik J, Pahor M et al. (1998): Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90: 1888-1893.
21. Raison CL, Miller AH (2003): Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 54: 283-294.
22. Spiegel D, Giese-Davis J (2003): Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54: 269-282.
23. Larson SL, Owens PL, Ford D, Eaton W (2001): Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 32: 1979-1983.
24. Moussavi SM, Chatterji SC, Verdes E et al. (2007): Depression, chronic diseases, and decrements in health: results from the World Health Survey. Lancet 370: 851-858.
25. Noel PH, Williams JW Jr, Unutzer J et al. (2004): Depression and comorbid illness in elderly primary care patients: impact on multiple domains of health status and well-being. Ann Fam Med 2: 555-562.
26. Kosloski K, Stull DE, Kercher K, Van Dussen DJ (2005): Longitudinal analysis of the reciprocal eff ects of self-assessed global health and depressive symptoms. J Gerontol B Psychol Sci Soc Sci 60: 296-303.
27. Katon W, Sullivan M, Russo J et al. (1993): Depressive symptoms and measures of disability: a prospective study. J Affect Disord 27: 245-254.
28. Global Burden of Disease 2004 Update: Selected figures and tables. World Health Organization 2008.
29. Summary: the global burden of disease. Boston: Harvard School of Public Health, 1996.
30. Forlenza MJ, Miller GE (2006): Increased Serum Levels of 8-Hydroxy-2′-Deoxyguanosine in Clinical Depression. Psychosom Med 68: 1-7.
31. Irie M, Miyata M, Kasai H (2005): Depression and possible cancer risk due to oxidative DNA damage. J Psych Res 39: 553-560.
32. Khanzode SD, Dakhale GN, Khanzode SS et al. (2003): Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors, Redox Rep 8: 365-370.
33. 2α and IL-6 in elderly population with depression. Psychiatry Research 161: 59-66.
34. Park YM, Han MY, Blackburn RV, Lee YJ (1998): Over-expression of HSP25 reduces the level of TNFalpha-induced oxidative DNA damage biomarker, 8-hydroxy-2′-deoxy-guanosine, in L929 cells. J Cell Physiol 174: 27-34.
35. Ohtaki H, Takaki A, Yin L et al. (2003): Suppression of oxidative stress after transient focal ischemia in interleukin-1 knock out mice. Acta Neurochir 86 (Suppl): 191-194.
36. Harman D (1956): Aging: a theory based on free radical and radiation chemistry. J. Gerontol 11: 298-300.
37. Harman D (1992): Free radical theory of aging. Mutat Res 275: 257-266.
38. Beckman KB, Ames BN (1998): The free radical theory of aging matures. Physiol Rev 78: 547-581.
39. Finkel T, Holbrook NJ (2000): Oxidants, oxidative stress and the biology of aging. Nature 408: 239-247.
40. Melov S, Ravenscroft J, Malik S et al. (2000): Extension of life-span with superoxide dismutase/catalse mimetics. Science 289: 1567-1569.
41. Mezzetti A, Lapenna D, Romano F et al. (1996): Systemic oxidative stress and its relationship with age and illness. Associazione Medica "Sabin". J Am Geriatr Soc 44: 823-827.
42. Harman D (1984): Free radical theory of aging: the free radical disease. Age 7: 111-131.
43. Martinez-Cayuela M (1995): Oxygen free radicals in human disease. Biochimie 77: 147-161.
44. Florenza MJ, Miller GE (2006): Increased serum levels of 8-hydroxy-2-deoxyguanosine in clinical depression. Psychosom Med 68: 1-7.
45. Bruunsgaard H, Pedersen M, Pedersen BK (2001): Ageing and proinflammatory cytokines. Curr Opin Hematol 8: 131-136.
46. Bruunsgaard H (2006): The clinical impact of systemic low-level inflammation in elderly populations. with special reference to cardiovascular disease, dementia and mortality. Danish Medical Bulletin 3: 285-309.
47. Gindali L. De Martinis M, D'Ostilio A et al. (1999): The immune system in elderly. Immunol Res 20: 117-126.
48. Alberti S, Cavenini E, Ostan R et al. (2006): Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4+ T cells in humans. Mech Ageing Dev 127: 560-566.
49. Rink L, Seyfarth M (1997): Characteristics of immunological test values in the elderly. Z Gerontol Geriatr 30: 220-225.
50. Haase H, Rink L (2009): The immune system and the impact of zinc during aging. Immun Ageing 6: 9.
51. Esumi E, Araga S, Takahashi K (2009): Serum interleukin-2 levels in patients with dementia of the Alzheimer type. Acta Neurologica Scandinavica 84: 65-67.
52. Sirnivasan V, Maestroni GJ, Cardinali DP et al. (2005): Melatonin, immune function and aging. Immun Ageing 2: 17.
53. Mariani E, Cattini L, Neri S et al. (2006): Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerentology 7: 449-459.
54. Csiszar A, Ungvari Z, Koller A et al. (2003): Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J 17: 1183-1185.
55. Krabbe KS, Pedersen M, Bruunsgaard H (2004): Inflammatory mediators in the elderly. Exp Gerontol 39: 687-699.
56. Bruunsgaard H, Pedersen BK (2003): Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 23: 15-39.
57. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg J et al. (2003): Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 115: 278-283.
58. Hasegawa Y, Sawada M, Ozaki N et al. (2000): Increased Soluble tumor necrosis factor receptor levels in the serum of elderly people. Gerontology 46: 185-188.
59. Wieczorkowska-Tobis K, Niemir ZI, Podkówka R et al. (2006): Can increased level of circulating IL-8 be a predictor of human longevity? Med Sci Monit 12: 118-121.
60. Pennix BW, Kritchevsky SB, Yaffe K et al. (1999): Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition Study. Biol Psychiatry 46: 1649-1655.
61. Thomas AJ, Davis S, Morris C et al. (2005): Increase in interleukin-1β in late-life depression. Am J Psychiatry 162: 172-177.
62. Tiemeier H, Hofman Albert, van Tuijl HR et al. (2003): Inflammatory proteins and depression in the elderly. Epidemiology 14: 103-107.
63. van den Biggelaar AHJ, Gussekloo J, de Craen AJM et al. (2007): Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 42: 693-701.
64. Karanfilov CI, Liu B, Fox CC et al. (1999): Age-related defects in Th1 and Th2 cytokine production by human T cells can be dissociate from altered frequencies of CD45RA+ and CD45RO+ T cell subsets. Mech Ageing Dev 109: 97-112.
65. Mariani E, Pulsatelli L, Meneghetti A et al. (2001): Different IL-8 production by T and NK lymphocytes in elderly subjects. Mech Ageing Dev 122: 1383-1395.
66. Solana R, Mariani E 2000: NK and NK/T cells in human senescence. Vaccine 18: 1613-1620.
67. Tsuboi H, Kawamura N, Hori R et al. (2005): Depressive symptoms and life satisfaction in elderly women are associated with natural killer cell number and cytotoxicity. Int J Behav 12: 236-243.
68. Evrin PE, Nilsson SE, Oberg T, Malmberg B (2005): Serum C-reactive protein in elderly men and women: association with mortality, morbidity and various biochemical values. Scand J Clin Lab Invest 65: 23-31.
69. Kuo H-K, Yen C-J, Chang C-H et al. (2005): Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 4: 371-380.
70. Ross R (1999): Atherosclerosis is an inflammatory disease. Am Heart J 138: 419-420.
71. Garton MJ, Keir G, Lakshmi MV, Thompson EJ (1991): Age-related changes in cerebrospinal fluid protein concentrations. J Neurol Sci 104: 74-80.
72. Tracey KJ (2002): The inflammatory reflex. Nature 420: 853-859.
73. Anisman H (2009): Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 34: 4-20.
74. Schulte-Herbrüggena O, Nassensteinb C, Lommatzschc M et al. (2005): Tumor necrosis factor-α and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol 160: 204-209.
75. Giacconi R, Cipriano C, Muzzioli M et al. (2003): Interrelationships among brain, endocrine and immune response in ageing and successful ageing: role of metallothionein III isoform. Mech Ageing Dev 124: 371-378.
76. Marcellini F, Giuli C, Papa R et al. (2007): Psychological and biochemical interactions in aging: preliminary results from an Italian old sample of "ZINCAGE" project. Arch Gerontol Geriatr 1 (Suppl): 259-269.
77. Beltramini M, Di Pisa C, Zambenedetti P et al. (2004): Zn and Cu alteration in connection with astrocyte metallothionein I/II overexpression in the mouse brain upon physical stress. Glia 47: 30-34.
78. Marcellini F, Giuli C, Papa R et al. (2006): Zinc status, psychological and nutritional assessment on old people recruited in five European countries: Zincage study. Biogerontology 7: 339-345.
79. Haase H, Moccheigani E, Rink L (2006): Correlation between zinc status and immune function in the elderly. Biogerontology 7: 421-428.
80. Varin A, Larbi A, Dedoussis GV et al. (2008): In vitro and in vivo effects of zinc on cytokine signalling in human T cells. Exp Gerontol 43: 472-482.
81. Mocchegiani E, Giacconi R, Costarelli L et al. (2008): Zinc deficiency and IL-6-174G/C polymorphism in old people from different European countries: effect of zinc supplementation. ZINCAGE study. Exp Gerontol 43: 433-444.
82. Marcellini F, Giuli C, Papa R et al. (2008): Zinc in elderly people: effects of zinc supplementation on psychological dimensions in dependence of IL-6-174 polymorphism: a Zincage study. Rejuvenation Res 11: 479-483.
83. Franco JL, Posser T, Brocardo PS et al. (2008): Involvement of glutathione, ERK 1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats. Behavioural Brain Research 188: 316-323.
84. Mocchegiani E, Giacconi R, Cipriano C et al. (2002): MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lesson from very old mice and humans. Exp Gerontol 37: 349-357.
85. Mocchegiani E, Muzzioli M, Giacconi R et al. (2003): Metallothioneines/ PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev 124: 459-468.
86. Mocchegiani E, Giacconi R, Cipriano C et al. (2002): Metallo-thioneines (I+II) and thyroid-thymus axis efficiency in old mice: role of corticosterone and zinc supply. Mech Ageing Dev 123: 675-694.
87. Tiemeier H, Fekkes D, Hofman A et al. (2006): Plasma pterins and folate in late life depression: The Rotterdam Study. Psychiatry Res 145: 199-206.
88. Forlenza MJ, Miller GE (2006): Increased Serum Levels of 8-Hydroxy-2′-Deoxyguanosine in Clinical Depression. Psychosom Med 68: 1-7.